Subclinical Atherosclerosis
Definition
Subclinical atherosclerosis is atherosclerotic plaque that is present in the arterial wall but has not yet produced a clinical event. It is detected by imaging — carotid and femoral ultrasound, coronary CT angiography, coronary artery calcium scoring or magnetic resonance imaging — rather than by symptoms. The concept matters because plaque burden predicts myocardial infarction, stroke and death independently of traditional risk factors, and because it is present decades before the first event. (sources/Silent-Atherosclerosis-NEJM-2026, rating: high)
Key Concepts
Measurement Modalities
| Modality | What it detects | Strengths | Limitations |
|---|---|---|---|
| Carotid and femoral 3D ultrasound | Peripheral plaque volume and territory involvement | No radiation; high diagnostic yield; feasible in young adults | Operator-dependent; does not image coronary arteries |
| Coronary CT angiography | Coronary plaque, stenosis, high-risk plaque features | Direct coronary anatomy and plaque burden | Radiation and contrast; requires adequate image quality; calcium blooming |
| Coronary artery calcium score | Calcified coronary plaque | Simple, reproducible, validated for risk reclassification | Misses noncalcified plaque; score of 0 does not exclude atherosclerosis |
| Cardiac MRI | Plaque and vessel wall | No ionizing radiation | Lower spatial resolution for coronary plaque; limited availability |
- The modalities answer different questions. Calcium scoring quantifies calcified burden and is the best-validated reclassification tool; CTCA detects noncalcified plaque and stenosis; ultrasound maps systemic territory involvement.
- Coronary plaque is frequently noncalcified in young adults. In REACT, among participants aged 30–39 with coronary plaque, 41.8% of men and 48.4% of women had a coronary calcium score of 0. (sources/Silent-Atherosclerosis-NEJM-2026, rating: high)
Prevalence across Adult Life — The REACT Atlas
| Age stratum | Men | Women |
|---|---|---|
| 18–29 years | 8.7% | 6.7% |
| 30–39 years | 34.6% | 21.3% |
| 60–70 years | 98.1% (only 1.9% had no plaque) | 91.9% (only 8.1% had no plaque) |
The 40–49 and 50–59 strata were not reported separately in the abstract; the overall age trajectory is described in the bullets below and in Figure 1 of the source.
- Overall prevalence was 57.1% in 13,186 participants with complete three-territory imaging; 63.4% in men and 50.9% in women.
- Prevalence rose earlier in men and more steeply in women after age 40. The adjusted odds ratio per 10-year increase in age was 4.52 in men and 3.85 in women.
- By age 60–70, atherosclerosis was near-universal: only 1.9% of men and 8.1% of women had no plaque in any examined territory.
- The sex difference narrowed with age, consistent with a later and steeper midlife rise in women, broadly overlapping the menopausal transition.
Vascular Territory Distribution
- In younger participants, atherosclerosis was usually peripheral and confined to one territory, most often carotid.
- Isolated coronary atherosclerosis was uncommon in every age stratum: at most 9.3% of men and 5.0% of women.
- Among participants with coronary plaque, 82.0% also had peripheral plaque, versus 41.5% of those without coronary plaque.
- The odds of coronary atherosclerosis rose with peripheral plaque volume: odds ratios 1.32, 1.85 and 3.70 across increasing quartiles versus no peripheral plaque.
- Multiterritorial disease increased with age: at 60–70, all three territories were involved in 56.3% of men and 30.7% of women.
Plaque Volume
- Median plaque volume among participants with plaque: carotid 23.9 mm³, femoral 44.8 mm³, combined peripheral 39.7 mm³ and coronary 74.7 mm³.
- Plaque volume increased with age in a pattern consistent with exponential growth; carotid and coronary plaque volume rose more steeply in men, while femoral growth was similar between sexes.
- This exponential pattern is cross-sectional, not within-person progression, but it is consistent with cumulative risk-factor exposure beginning early in life.
Risk Scores versus Imaging
- Participants with silent atherosclerosis were older, had more risk factors and higher SCORE2 risk than those without plaque.
- A high SCORE2 risk classification identified only 0.5% of participants with single-territory disease and 3.8% of those with combined peripheral and coronary disease.
- High SCORE2 risk was highly specific (99.8%) but had low sensitivity (1.9%) for silent atherosclerosis; moderate-to-high SCORE2 risk had specificity 87.9% and sensitivity 34.1%.
- The discordance was greatest in younger participants and persisted after excluding participants on lipid-lowering or antihypertensive therapy.
- Risk scores and imaging capture different information. A risk score estimates the probability of an event over a fixed horizon and is dominated by age; imaging detects the disease itself, including in young adults whom the score assigns to low risk. (sources/Silent-Atherosclerosis-NEJM-2026, rating: high; sources/lipid-aha-2026, rating: very high)
Implications for Primary Prevention
- Detection in young adults may identify a population at increased long-term risk at a stage when risk-factor control has the greatest potential benefit.
- Carotid ultrasound had the highest diagnostic yield, but 18% of people with femoral but not carotid plaque would be missed by carotid imaging alone.
- Calcium scoring alone does not exclude early coronary atherosclerosis, and a score of 0 should not be interpreted as absence of disease in a young symptomatic or high-risk patient.
- The 2026 ACC/AHA lipid guideline already uses CAC scoring to reclassify intermediate-risk adults; REACT extends the argument to earlier ages and to noncoronary territories. (sources/lipid-aha-2026)
Contradictions / Open Questions
- Prevalence is not prognosis. REACT describes who has plaque and where, but it is cross-sectional and does not report incident cardiovascular events. Whether detecting silent atherosclerosis in a 30-year-old improves outcomes compared with risk-factor-based care is untested.
- The study is a cross-sectional atlas, not a natural-history study. Age-related patterns should not be read as within-person progression; the exponential plaque-volume curve could reflect cohort effects, survival or secular trends rather than individual growth.
- Enrollment was stratified, not population-weighted. The overall 57.1% prevalence is an estimate for the sampled age-sex-country strata, not a prevalence for the general population.
- Healthy-participant bias likely underestimates disease. Participants without known ASCVD who volunteer for imaging are likely healthier than the population; the true prevalence and extent may be higher.
- Imaging-based screening has no proven outcome benefit. No trial has shown that detecting subclinical atherosclerosis and intensifying therapy reduces events more than guideline-based risk-factor treatment. The case for screening rests on association and biological plausibility.
- A calcium score of 0 is not a rule-out in young adults. Noncalcified plaque was common in the youngest strata with plaque; using calcium scoring alone would misclassify a substantial proportion of early coronary disease.
- Which territory should be imaged, and when? Carotid ultrasound is the highest-yield single test in this cohort, but coronary CT adds coronary-specific information and femoral imaging catches a further 18%. The optimal screening package, interval and population are undefined.
- The sex-specific trajectory has no clinical algorithm. Women develop plaque later but with a steeper midlife rise; whether screening should start later in women, or at the same age, is unresolved.
- Statin use may confound the calcium trajectory. The marked increase in coronary calcification after age 50 may partly reflect higher statin use in older participants, particularly men, rather than disease progression alone.
Connections
- Part of concepts/Atherosclerosis-Pathophysiology — the plaque biology underlying the imaging findings
- concepts/ASCVD-Risk-Assessment — PREVENT, SCORE2 and CAC-based reclassification
- concepts/Dyslipidemia — LDL-C and non-HDL-C as modifiable drivers of plaque
- concepts/Coronary-Microvascular-Dysfunction — a nonobstructive mechanism of ischemia in the same population
- entities/Obesity — a risk factor and a driver of accelerated atherosclerosis
- entities/Type-2-Diabetes — a risk factor and a driver of accelerated atherosclerosis